Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/Ib Study of Olaparib and ASTX727 in BRCA1/2- and HRD-mutated Tumors

NCT06177171 is registered in ClinicalTrials.gov with Varun Monga, MBBS as lead sponsor.

NCT NCT06177171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/Ib Study of Olaparib and ASTX727 in BRCA1/2- and HRD-mutated Tumors
Lead sponsor
Varun Monga, MBBS
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 7, 2024
Completion date
January 31, 2028
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atm gene mutation, brca mutation, brca1 mutation, brca2 mutation, checkpoint kinase 2 gene mutation, palb2 gene mutation